G-NiiB Immunity+ SIM01 Probiotics, 28 Days x 1

GenieBiome - Leader in Microbiometic Biotechnology 

- Founded by world-renowned clinician-scientists

- Exclusive patent licensing from The Faculty of Medicine of a Renowned University in Hong Kong.

- Supported by experts in microbiology, metagenomics, bioinformatics, disease biomarkers, food technology, clinical trials, IP development, commercialization

- Evidence-based science to tackle novel virus, gut serious illness, overweight and metabolic syndrome, skin irritation, mental health

- Diagnostic and risk prediction tests, precision medicine tailored for the Asian population

Key Benefits:

-  Relieves: Gastron-instestinal discomforts (Softens Stool, increases stool bulk, relieve Bloating)

-  Promotes Skin Health & Healing  

-  Restores gut flora after antibiotic use

-   Relief post-recovery symptoms: digestive problems, fatigue, difficulty in concentrating, memory loss, general unwellness2

G-NIIB Immunity+ in our body:

- Build immunity by directly blocking intestinal pathogenic microbes3

- Enhance gastrointestinal mucosal membrane health

- Increases immune cells

- Restores the Balance of Gut Microbiome

- Reduce the risk of viral and bacterial infections

G-NIIB Immunity+ and Quality of Life:

- Enhances positive mood by 85%4

- Improve sleep quality by 115%4

- Improves skin quality by 101%4

Why G-NIIB?

- Patented golden ratio formula5

- Designed & Tailored For Asians6

- Patented Microencapsulation Technology from Italy allows for more than 250% improved survival rate of live bacteria, - enhancing product effectiveness7

- Gut colonization efficiency of microencapsulated probiotic bacteria is 5 times higher vs (same) non-encapsulated strains8

Footnotes:

1Jessica C et al. Modulation of Gut Microbiome alleviates post-acute COVID-19 syndrome: A randomized, triple blind, placebo controlled trial (RECOVERY STUDY). In: Digestive Disease Week 2023; 09 May 2023; Hong Kong.

2Based on clinical study data from The Faculty of Medicine of a Renowned University in Hong Kong. All participants received at least two doses of COVID vaccine.

³ Wong, M.C.S.; Zhang, L.; Ching, J.Y.L.; Mak, J.W.Y.; Huang, J.; Wang, S.; Mok, C.K.P.;Wong, A.; Chiu, O.-L.; Fung, Y.-T.; et al. Effects of Gut Microbiome Modulation on Reducing Adverse Health Outcomes among Elderly and Diabetes Patients during the COVID-19 Pandemic: A Randomised, Double-Blind, Placebo-Controlled Trial (IMPACT Study). Nutrients 2023, 15, 1982. https://doi.org/10.3390/nu15081982.

4Gourbeyre P. et al., 2010 Probiotics, prebiotics, and synbiotics: impact on the gut immune system and allergic reactions

5Liang JQ, Zeng Y, Lau EYT, et al. A Probiotic Formula for Modulation of Colorectal Cancer Risk via Reducing CRC-Associated Bacteria. Cells. 2023;12(9):1244.

6Centre of Gut Microbiota Research, The Chinese University of Hong Kong. Internal data

71. Del Piano M. et al. In Vitro Sensitivity of Probiotics to Human Pancreatic Juice. J Clin Gastroenterol. 2008; 42 (3): S170-173. 2. Charteris WP. et al. Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J Appl Microbiol. 1998; 84 (5): 759-768

8J Clin Gastroenterol 2010; 44:42–6 DOI: 10.1097/MCG.0b013e3181ed0e71